
Organometallics p. 1550 - 1560 (2008)
Update date:2022-07-29
Topics:
Begum, Noorjahan
Hyder, Md. Iqbal
Hassan, Mohammad R.
Kabir, Shariff E.
Bennett, Dennis W.
Haworth, Daniel T.
Siddiquee, Tasneem A.
Rokhsana, Dalia
Sharmin, Ayesha
Rosenberg, Edward
Reactions of [Ru3(CO)10(μ-dppm)] (1) and its ortho-metalated derivative [Ru3(CO)9{μ3- η3-P(C6H5)CH2P(C 6H5)(C6H4)}] (11) with PhEEPh (E = Te, Se, S) have been investigated. Treatment of 1 with PhTeTePh at room temperature afforded the dinuclear compound [Ru2(CO) 4(μ-TePh)2(μ-dppm)] (2) and the 54-electron triruthenium compounds [Ru3(CO)6(μ3-Te) 2(μ-TePh)2(μ-dppm)] (3) and [Ru3(CO) 6(μ3-Te)(μ-TePh)3(η1-COPh) (μ-dppm)] (4). Analogous reactions of 1 with PhEEPh (E = Se, S) led to [Ru2(CO)4(μ-EP[Ru3(CO)6(μ 3-E)2(μ-EPh)2(μ-dppm)]) 2(μ-dppm)] (E = Se, 5; E = S, 8) and the 54-electron triruthenium compounds (E = Se, 6; E = S, 9), and [Ru3(CO) 6(μ3-E)(μ-EPh)3(Ph)(μ-dppm)] (E = Se, 7; E = S, 10). Reactions of the ortho-metalated complex 11 with PhEEPh (E = Te, Se, S) in refluxing THF gave exclusively [Ru3(CO)6(μ- EPh)2{μ3-η3-P(C6H 5)CH2P(C6H5)(C6H 4)}] (E = Te, 12; E = Se, 13; E = S, 14). The new compounds have been characterized by a combination of analytical and spectroscopic methods, and molecular structures of 2-4, 7, 10, and 13 have been determined by single-crystal X-ray diffraction studies. Compounds 2, 5, and 8 have the classical sawhorse structure with two bridging EPh (E = Te, Se, S) moieties and one bridging dppm ligand. Compounds 3, 6, and 9 contain a Ru 3 framework with two bridging EPh (E = Te, Se, S) groups, one bridging dppm ligand, and two capping chalcogenido ligands. Compound 4 contains an Ru3 core with a capping tellurido ligand, three bridging TePh moieties, one bridging dppm ligand, and a terminally coordinated benzoyl group, formed from multiple fragmentation of the PhTeTePh ligand and migratory insertion of a Ph group into a CO ligand. Compounds 7 and 10 comprise a capping chalcogenido ligand, three bridging EPh (E = Se, 7; E = S, 10) moieties, a bridging dppm ligand, and a terminally coordinated σ-bonded phenyl group. In compounds 12-14, the coordination of ortho-metalated diphosphine ligand is the same as in 11 and both the EPh moieties bridge the same unbridged Ru-Ru edge. Compounds 3, 6, 7, and 10 exhibit restricted fluxional behavior involving the μ-EPh moieties.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Shanghai He Yang International Trading Co., Ltd.
Contact:+86-21-52043598
Address:Room 816, Blag.5, No.58 Huachi Road
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Doi:10.1021/jo702210c
(2008)Doi:10.1021/om701077y
(2008)Doi:10.1021/ja800025u
(2008)Doi:10.1007/s10593-006-0124-0
(2006)Doi:10.1021/ja00086a057
(1994)Doi:10.1016/S0040-4020(01)86099-3
(1988)